Davis Aaron I.
- SEC CIK
- 0001465914
No open-market purchases or sales filed in the past year.
Current role at each company
- TNGX Tango Therapeutics, Inc.Other: See remarksas of Nov 7, 2024
- ITOS iTeos Therapeutics, Inc.Directoras of Jun 13, 2024
- TYRA Tyra Biosciences, Inc.Other: See Remarksas of Feb 8, 2024
- Rain Oncology Inc.Directoras of Jan 26, 2024
- MRTX Mirati Therapeutics, Inc.Other: See remarksas of Jan 25, 2024
Show 1 more company
- ODT Odonate Therapeutics, Inc.Director, 10% Owneras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Davis Aaron I. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TNGX Tango Therapeutics, Inc.
Other: See remarks10 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2024 (view filing)9:30 PM ET | Nov 6 | 1 day | Davis Aaron I. and 1 otherOther: See remarks | SSale | −3.08M | $3.14 | −$9.67M | −46.0%3.61M after | |
| Oct 28, 2024 (view filing)6:59 AM ET | Oct 25 | 3 days | Davis Aaron I. and 1 otherOther: See remarks. | SSale | −633.0K | $6.87 | −$4.35M | −8.6%6.69M after | |
| Oct 23, 2024 (view filing)9:31 PM ET | Oct 21-22 | 2 days | Davis Aaron I. and 1 otherOther: See remarks | SSale | −875.0K | $6.97 | −$6.10M | −10.7%7.32M after | 2 lots |
| Jul 2, 2024 (view filing)8:56 PM ET | Jun 28-Jul 2 | 4 days | Davis Aaron I. and 1 otherOther: See remarks | SSale | −234.7K | $8.76 | −$2.06M | −68.3%108.8K after | 3 lots |
| Jun 7, 2024 (view filing)9:14 PM ET | Jun 6-7 | 1 day | Davis Aaron I. and 1 otherOther: See remarks | SSale | −140.0K | $7.04 | −$985.9K | −29.0%343.5K after | 2 lots |
| May 3, 2024 (view filing)9:34 PM ET | May 1-3 | 2 days | Davis Aaron I. and 1 otherOther: See remarks | SSale | −210.0K | $7.53 | −$1.58M | −30.3%483.5K after | 3 lots |
| Oct 17, 2023 (view filing)7:41 PM ET | Oct 13-16 | 4 days | Lewis Joseph and 4 othersOther: See remarks | PPurchase | +1.25M | $6.98 | +$8.72M | +18.0%8.20M after | Amended2 lots |
| Oct 11, 2023 (view filing)9:22 PM ET | Oct 9 | 2 days | Lewis Joseph and 4 othersOther: See remarks | SSale | −50.0K | $9.91 | −$495.5K | −6.7%693.5K after | |
| Oct 11, 2023 (view filing)9:22 PM ET | Oct 9 | 2 days | Lewis Joseph and 4 othersOther: See remarks | SSale | −175.0K | $9.97 | −$1.74M | −2.5%6.95M after | |
| Oct 13, 2022 (view filing)9:30 PM ET | Oct 11-13 | 2 days | Davis Aaron I. and 4 othersDirector, 10% Owner | PPurchase | +237.0K | $4.41 | +$1.04M | +3.4%7.12M after | 3 lots |
ITOS iTeos Therapeutics, Inc.
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2023 (view filing)9:28 PM ET | Aug 23 | 2 days | Lewis Joseph and 3 othersOther: See remarks | SSale | −350.0K | $16.26 | −$5.69M | −16.2%1.80M after | 3 lots |
| May 11, 2022 (view filing) | May 9-11 | 2 days | Davis Aaron I.Director | SSale | −663.0K | $21.04 | −$14.0M | −23.5%2.15M after | 6 lots |
| May 2, 2022 (view filing) | Apr 28-May 2 | 4 days | Davis Aaron I.Director | SSale | −375.0K | $27.32 | −$10.2M | −11.7%2.82M after | 5 lots |
| Mar 24, 2022 (view filing) | Mar 22-23 | 2 days | Davis Aaron I.Director | PPurchase | +50.0K | $32.51 | +$1.63M | +1.6%3.19M after | 4 lots |
| Jan 5, 2022 (view filing)9:20 PM ET | Jan 3-4 | 2 days | Boxer Capital, LLC and 4 othersDirector, 10% Owner | SSale | −700.0K | $46.54 | −$32.6M | −100.0%0 after | 14 lots |
MRTX Mirati Therapeutics, Inc.
Other: See remarks4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 (view filing)9:39 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +57.5K | $27.80 | +$1.60M | +25.0%287.9K after | Duplicate filing |
| Aug 15, 2023 (view filing)9:39 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +1.20M | $27.80 | +$33.4M | +60.1%3.20M after | Duplicate filing |
| Aug 15, 2023 (view filing)9:38 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +57.5K | $27.80 | +$1.60M | +25.0%287.9K after | |
| Aug 15, 2023 (view filing)9:38 PM ET | Aug 11 | 4 days | Lewis Joseph and 6 othersOther: See remarks | PPurchase | +1.20M | $27.80 | +$33.4M | +60.1%3.20M after |
Rain Oncology Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 (view filing)8:05 PM ET | May 22 | 2 days | Davis Aaron I. and 3 othersDirector | SSale | −995.0K | $1.25 | −$1.24M | −46.3%1.15M after | |
| Nov 8, 2022 (view filing) | Nov 4 | 4 days | Davis Aaron I.Director | PPurchase | +972.2K | $5.83 | +$5.67M | +82.7%2.15M after | |
| Nov 8, 2022 (view filing) | Nov 4 | 4 days | Davis Aaron I.Director | PPurchase | +400.0K | $5.83 | +$2.33M | –3.42M after | Derivative |
TYRA Tyra Biosciences, Inc.
Other: See Remarks2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 (view filing)9:39 PM ET | Feb 9-10 | 4 days | Davis Aaron I. and 1 other10% Owner | SSale | −265.6K | $13.17 | −$3.50M | −92.2%22.5K after | 2 lots |
| Sep 17, 2021 (view filing)4:38 PM ET | Sep 17 | Same day | Lewis Joseph and 4 others10% Owner | PPurchase | +625.0K | $16.00 | +$10.0M | +11.0%6.32M after |
ODT Odonate Therapeutics, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing) | Nov 17-19 | 2 days | Davis Aaron I.Director, 10% Owner | SSale | −200.0K | $2.18 | −$436.7K | −31.0%445.8K after | 2 lots |
| Nov 19, 2021 (view filing) | Nov 17-19 | 2 days | Davis Aaron I.Director, 10% Owner | SSale | −1.00M | $2.07 | −$2.07M | −17.8%4.61M after | 3 lots |